|
Q4 FY2026
As of Aug 31, 2026
|
Q3 FY2026
As of May 31, 2026
|
Q2 FY2026
As of Feb 28, 2026
|
Q1 FY2026
As of Nov 30, 2025
|
Q4 FY2025
As of Aug 31, 2025
|
Q3 FY2025
As of May 31, 2025
|
Q2 FY2025
As of Feb 28, 2025
|
Q1 FY2025
As of Nov 30, 2024
|
Q4 FY2024
As of Aug 31, 2024
|
Q3 FY2024
As of May 31, 2024
|
Q2 FY2024
As of Feb 29, 2024
|
Q1 FY2024
As of Nov 30, 2023
|
Q4 FY2023
As of Aug 31, 2023
|
Q3 FY2023
As of May 31, 2023
|
Q2 FY2023
As of Feb 28, 2023
|
Q1 FY2023
As of Nov 30, 2022
|
Q4 FY2022
As of Aug 31, 2022
|
Q3 FY2022
As of May 31, 2022
|
Q2 FY2022
As of Feb 28, 2022
|
Q1 FY2022
As of Nov 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Trade and other accounts receivable, net | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other intangible assets, net | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Right-of-use assets | ||||||||||||||||||||
| Deferred tax assets, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Stockholders’ Equity | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued liabilities | ||||||||||||||||||||
| Accrued payroll and related expenses | ||||||||||||||||||||
| Short-term borrowings | ||||||||||||||||||||
| Income taxes payable | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term borrowings | ||||||||||||||||||||
| Deferred tax liabilities, net | ||||||||||||||||||||
| Long-term operating lease liabilities | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||||
| Common stock — authorized 36,000,000 shares, $0.001 par value; 19,974,002 and 19,954,495 shares issued at August 31, 2026 and 2025, respectively; and 13,407,301 and 13,527,614 shares outstanding at August 31, 2026 and 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Common stock held in treasury, at cost — 6,566,701 and 6,426,881 shares at August 31, 2026 and 2025, respectively | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
Loading...
